Vira Shield 6 L5 [50 mL] (10 Doses)

Vira Shield 6 is for use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Types 1 & 2), parainfluenza Type 3 (PI3) and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae and pomona. Produced from non-cytopathic (BVD Types 1 & 2) and cytopathic (BVD Type 1) isolates. "In the real world, where the BVD virus is constantly mutating, producers need the most updated and broadest spectrum BVD vaccine available," says John Landon, Novartis bovine marketing manager. "Vira Shield 6 offers broad spectrum protection as it is the first vaccine to contain three BVD antigens."

In addition to BVD, new Vira Shield 6 combinations protect animals against IBR, PI3, BRSV and even HB. somnus when producers use new Vira Shield 6+Somnus The new product is safe for use in any cow, bull or calf in any stage of production. Vira Shield 6 can be given to calves at pre-weaning and weaning to prepare them for the stresses of weaning and entry into the herd or feedlot. The new product is approved for subcutaneous-only administration and complements both beef and dairy health programs supporting beef quality assurance. It contains the proprietary Xtend SP adjuvant technology for higher immunity over a longer period of time.

Flexible: Easy to implement into any management program or whole-herd protocol, unlike vaccines that carry label restrictions and products that require cows to be vaccinated prior to breeding

Safe: Vira Shield 6 combinations are for cattle at all stages of production, including pregnant cows, heifers and calves nursing pregnant cows. It has been shown to deliver enhanced Infectious Bovine Rhinotracheitis (IBR) fetal protection eight months post vaccination.

Directions/Dosage: Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur.

Powerful & Long Lasting Control: Consistently produces higher litters due to state-of-the-art adjuvant (Xtend SP), prolonging stimulation of the immune system.

Vira Shield 6 L5 [50 mL] (10 Doses) Highlights:

• SKU: 12331
• Manufacturer: Elanco
• Use entire contents when first opened.
• Do not vaccinate within 60 days prior to slaughter.
• Transient swelling may occur at the site of injection.
• Bovine Rhinotracheitis (IBR) fetal protection eight months post vaccination.
• Produced from non-cytopathic (BVD Types 1 & 2) and cytopathic (BVD Type 1) isolates.
• Vira Shield 6 offers broad spectrum protection as it is the first vaccine to contain three BVD antigens.
• Consistently produces higher litters due to state-of-the-art adjuvant (Xtend SP), prolonging stimulation of the immune system.